- 503-38-8Carbonochloridic acid,trichloromethyl ester
- 50-33-94-Butyl-1,2-diphenyl-3,5-dioxopyrazolidine
- 50-34-02-Propanaminium,N-methyl-N-(1-methylethyl)-N-[2-[(9H-xanthen-9-ylcarbonyl)oxy]ethyl]-, bromide(1:1)
- 503-40-2Methanedisulfonic acid
- 5034-06-0Sulfoxonium,trimethyl-, chloride (8CI,9CI)
- 50340-79-92,5-Thiophenedicarboxylicacid, 2-methyl ester
- 503417-29-6Cyclopropanamine, 1-(2-methylphenyl)- (9CI)
- 503417-30-9Cyclopropanamine, 1-(3-methylphenyl)- (9CI)
- 503417-36-5Benzonitrile, 3-(1-aminocyclopropyl)-
- 503417-37-6Cyclopropanamine, 1-(2-pyridinyl)- (9CI)
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Chaetoglobosin A |
EINECS | N/A |
| CAS No. | 50335-03-0 | Density | 1.3 g/cm3 |
| PSA | 111.79000 | LogP | 4.16120 |
| Solubility | N/A | Melting Point |
188°C |
| Formula | C32H36 N2 O5 | Boiling Point | 789.7 °C at 760 mmHg |
| Molecular Weight | 528.648 | Flash Point | 431.4 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by ingestion, intraperitoneal, and subcutaneous routes. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
[13]Cytochalasa-13,17,21-triene-1,20,23-trione,6,7-epoxy-19-hydroxy-10-(1H-indol-3-yl)-16,18-dimethyl-,(7S,13E,16S,17E,19R,21E)-;3H-Cyclotridec[d]oxireno[f]isoindole-8,11,12(13H)-trione, 4,7,14,14a,15,15a,16a,16b-octahydro-7-hydroxy-14-(1H-indol-3-ylmethyl)-4,6,15,15a-tetramethyl-,[4S-(1E,4R*,5E,7S*,9E,11aS*,14R*,14aS*,15R*,15aS*,16aR*,16bS*)]-;Chaetoglobosin A |
Chaetoglobosin A Chemical Properties
Product Name: Chaetoglobosin A
Synonyms of Chaetoglobosin A (CAS NO.50335-03-0) : (13)Cytochalasa-13,17,21-triene-1,20,23-trione, 6,7-epoxy-19-hydroxy-10-(1H-indol-3-yl)-16,18-dimethyl-, (7S,13E,16S,17E,19R,21E)- ; (1E,4S,5E,7R,9E,11aR,14S,14aR,15S,15aR,16aS,16bR)-7-Hydroxy-14-(1H-indol-3-ylmethyl)-4,6,15,15a-tetramethyl-4,7,14,14a,15,15a,16a,16b-octahydro-3H-cyclotrideca[d]oxireno[f]isoindole-8,11,12(13H)-trione ; 3H-cyclotridec[d]oxireno[f]isoindole-8,11,12(13H)-trione, 4,7,14,14a,15,15a,16a,16b-octahydro-7-hydroxy-14-(1H-indol-3-ylmethyl)-4,6,15,15a-tetramethyl-, (1E,4S,5E,7R,9E,11aR,14S,14aR,15S,15aR,16aS,16bR)-
CAS NO:50335-03-0
Molecular Formula:C32H36N2O5
Molecular Weight :528.6386
Molecular Structure :.png)
Index of Refraction: 1.651
Surface Tension: 61.2 dyne/cm
Density: 1.3 g/cm3
Flash Point: 431.4 °C
Enthalpy of Vaporization: 120.48 kJ/mol
Boiling Point: 789.7 °C at 760 mmHg
Vapour Pressure: 2.78E-26 mmHg at 25°C
Chaetoglobosin A Uses
Chaetoglobosin A (CAS NO.50335-03-0) is used as intermediate in organic synthesis.
Chaetoglobosin A Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | oral | > 400mg/kg (400mg/kg) | Japanese Journal of Experimental Medicine. Vol. 48, Pg. 105, 1978. | |
| mouse | LD50 | subcutaneous | 6500ug/kg (6.5mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA | Japanese Journal of Experimental Medicine. Vol. 48, Pg. 105, 1978. |
| rat | LD50 | oral | > 400mg/kg (400mg/kg) | Japanese Journal of Experimental Medicine. Vol. 48, Pg. 105, 1978. | |
| rat | LDLo | intraperitoneal | 2mg/kg (2mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES GASTROINTESTINAL: OTHER CHANGES LIVER: OTHER CHANGES | Japanese Journal of Experimental Medicine. Vol. 48, Pg. 105, 1978. |
Chaetoglobosin A Safety Profile
Poison by ingestion, intraperitoneal, and subcutaneous routes. Experimental reproductive effects. When Chaetoglobosin A (CAS NO.50335-03-0) is heated to decomposition ,it emits toxic fumes of NOx.
What can I do for you?
Get Best Price
